Lamivudine resistance in chronic hepatitis B [1]

Journal of Hepatology

Volumn 28, Issue 1, 1998, Pages 169-

  Atkins, M ^a   Fraser Gray, D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE;

CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SENSITIVITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031936048     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(98)80219-5     Document Type: Letter

References (2)

1. P Honkoop GM Hubert RAM de Man ADME Osterhaus SW Schalm Lamivudine resistance in immunocompetent chronic hepatitis B J Hepatol 26 1997 1393 1395
2. CL Lai YF Liaw NWY Leung TT Chang R Guan DI Tai Twelve months of lamivudine (100 mg od) therapy improves liver histology: results of a placebo controlled multicentre study in Asia [abstract] J Hepatol 26 1997 79 (Suppl 1)